By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Lexicon Pharmaceuticals, Inc. 

8800 Technology Forest Place

The Woodlands  Texas  77381-1160  U.S.A.
Phone: 281-863-3000 Fax: 281-863-8088



Company News
Lexicon Pharma (LXRX) Collaborator Ipsen (IPN.PA) Receives Positive CHMP Opinion For Xermelo (Telotristat Ethyl) 7/21/2017 6:52:01 AM
Lexicon Pharma (LXRX) Release: NCCN Guidelines For Neuroendocrine Tumors Include XERMELO In Combination With Somatostatin Analog Therapy As A Recommended Treatment Option For Patients With Carcinoid Syndrome Diarrhea 6/19/2017 6:37:56 AM
Lexicon Pharma (LXRX) Release: Sotagliflozin Data From Pivotal inTandem1 And inTandem2 Studies In Patients With Type 1 Diabetes Presented At American Diabetes Association 2017 6/12/2017 6:58:30 AM
Lexicon Pharma (LXRX) Surges On Positive Phase III For New Diabetes Drug 6/9/2017 5:41:28 AM
Lexicon Pharma (LXRX) Reports Additional Positive Data From Pivotal InTandem1 Phase III Study For Sotagliflozin In Patients With Type 1 Diabetes 5/11/2017 7:32:46 AM
Lexicon Pharma (LXRX) Reports First Quarter 2017 Financial Results And Provides A Business Update 5/3/2017 10:24:32 AM
Lexicon Pharma (LXRX) To Host First Quarter 2017 Financial Results Conference Call And Webcast On May 2, 2017 5/1/2017 8:06:44 AM
Lexicon Pharma (LXRX) Provides Clinical Pipeline Update And Reports 2016 Fourth Quarter And Full Year Financial Results 3/3/2017 7:36:48 AM
Lexicon Pharma (LXRX) To Report Fourth Quarter And Year End 2016 Financial Results On March 3, 2017 3/2/2017 9:21:55 AM
FDA Says Yes to Lexicon Pharma (LXRX)'s Carcinoid Syndrome Diarrhea Drug, Stock Soars 3/1/2017 5:50:08 AM